Topics
September 2017 | Special Feature
The Eye as a Window for Early Diagnosis of Obstructive Sleep Apnea
Objective measures on OCTA may allow more effective management of this common condition.
Lauren Lombardi; Lotem Nativ; Omar Helmy, MD; and Shlomit Schaal, MD, PhD
November 9, 2026
Viridian Therapeutics Reports Positive Phase 1 Results for VRDN-008, Plans Registrational Trial in 2027
Ianalumab Reduces Disease Activity in Sjögren’s Disease in Two Phase 3 Trials
November 6, 2026
VeonGen Therapeutics Secures FDA Alignment on Phase 3 Development of VG801 for Stargardt Disease
November 5, 2026
Prism Vision Group Acquires Spectrum Vision Partners, Expanding Ophthalmology Network Across Five States
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
